Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$9.97

-0.54 (-5.14%)

06:48
04/06/18
04/06
06:48
04/06/18
06:48

Fate Therapeutics approach validated by MD Anderson data, says Wells Fargo

Wells Fargo analyst Jim Birchenough reiterates an Outperform rating on Fate Therapeutics with an $18 price target following review of the initial clinical results from an "off-the-shelf" NK-cell therapeutic from MD Anderson. The results validate Fate's own platform of NK-cell therapeutics, including off-the-shelf induced pluripotent stem cell derived FATE-NFT500 and engineered NK-CAR candidates like FATE-FT519 targeting CD19, Birchenough tells investors in a research note. He notes that MD Anderson presented a clinical update from a first-inpatient phase 1/2 trial of a cord blood derived natural killer cell CD19 chimeric antigen receptor.

FATE Fate Therapeutics
$9.97

-0.54 (-5.14%)

03/06/18
03/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Spectra Energy Partners (SEP) downgraded to Hold from Buy at Stifel with analyst Selman Akyol saying he believes the company's cash flow growth will be on the low end relative to its large cap peers. 2. GrubHub (GRUB) downgraded to Neutral from Buy at BofA/Merrill with analyst Nat Schindler. citing valuation. 3. Canadian National (CNI) downgraded to Underperform from Neutral at BofA/Merrill with analyst Ken Hoexter saying CEO Luc Jabin stepped down at a time when the company's pace of growth is set to stagnate as rising costs to maintain service levels offset volume and pricing gains. 4. General Mills (GIS) downgraded to Hold from Buy at Gabelli. 5. Fate Therapeutics (FATE) was downgraded to Market Perform from Outperform at Raymond James and to Neutral from Buy at H.C. Wainwright. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/15/18
PIPR
03/15/18
NO CHANGE
Target $20
PIPR
Overweight
Fate Therapeutics remains a 2018 top pick at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says Fate Therapeutics remains a 2018 top pick for off-the-shelf Natural Killer cell therapy with clinical data and pipeline expansion this year. With Phase I ovarian cancer data this month, the analyst reiterates an Overweight rating on the shares with a $20 price target.
03/29/18
PIPR
03/29/18
NO CHANGE
Target $20
PIPR
Overweight
Fate Therapeutics Phase I data on NK100 'highly' encouraging, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff said he was "highly encouraged" by the preliminary safety and efficacy data from a Phase I trial on Fate Therapeutics' NK100 in two ovarian cancer patients that was presented at a medical summit. The first patient progressed and the second had stable disease at 28 days with early signs of tumor regression, he noted. Tenthoff said Fate remains a 2018 top pick and reiterated his Overweight rating and $20 price target on the shares.
03/29/18
HCWC
03/29/18
NO CHANGE
HCWC
Fate Therapeutics initial data for FATE-NK100 encouraging, says H.C. Wainwright
H.C. Wainwright analyst Edward White reiterated a Hold rating and $12 price target on Fate Therapeutics, noting the initial clinical data for FATE-NK100 that was announced earlier Thursday is encouraging, and saying the Hold rating is a reflection of the current stock price and not a "diminished outlook" for FATE-NK100.

TODAY'S FREE FLY STORIES

08:40
11/21/18
11/21
08:40
11/21/18
08:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

SOLO

ElectraMeccanica

$1.39

-0.12 (-7.95%)

08:38
11/21/18
11/21
08:38
11/21/18
08:38
Hot Stocks
ElectraMeccanica CFO Kulwant Sandher to depart, Bal Bhullar to succeed »

ElectraMeccanica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 04

    Dec

LOW

Lowe's

$86.15

-5.19 (-5.68%)

08:36
11/21/18
11/21
08:36
11/21/18
08:36
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$4.85

-1.04 (-17.66%)

, FIX

Comfort Systems USA

$52.64

-1.06 (-1.97%)

08:35
11/21/18
11/21
08:35
11/21/18
08:35
Recommendations
Limbach Holding, Comfort Systems USA, Emcore analyst commentary  »

Limbach Holding price…

LMB

Limbach Holding

$4.85

-1.04 (-17.66%)

FIX

Comfort Systems USA

$52.64

-1.06 (-1.97%)

EMKR

Emcore

$4.42

-0.02 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:34
11/21/18
11/21
08:34
11/21/18
08:34
General news
Jobless Claims data reported »

Week of 11/17 Jobless…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

08:33
11/21/18
11/21
08:33
11/21/18
08:33
Recommendations
DexCom, Alphabet, Alphabet Class A analyst commentary  »

Verily collaboration more…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

LUXTY

Luxottica

$0.00

(0.00%)

08:31
11/21/18
11/21
08:31
11/21/18
08:31
Downgrade
Luxottica rating change  »

Luxottica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$57.86

0.5 (0.87%)

, DE

Deere

$138.49

-4.04 (-2.83%)

08:29
11/21/18
11/21
08:29
11/21/18
08:29
Hot Stocks
Agco drops 2% after Deere issues FY19 guidance »

Shares of farm equipment…

AGCO

Agco

$57.86

0.5 (0.87%)

DE

Deere

$138.49

-4.04 (-2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

USCR

U.S. Concrete

$34.14

-1.6 (-4.48%)

08:25
11/21/18
11/21
08:25
11/21/18
08:25
Recommendations
U.S. Concrete analyst commentary  »

U.S. Concrete price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

HUM

Humana

$307.50

-2.87 (-0.92%)

, WBA

Walgreens Boots Alliance

$79.82

-2.11 (-2.58%)

08:25
11/21/18
11/21
08:25
11/21/18
08:25
Recommendations
Humana, Walgreens Boots Alliance, Amazon.com, CVS Health, Aetna, UnitedHealth analyst commentary  »

Humana-Walgreens…

HUM

Humana

$307.50

-2.87 (-0.92%)

WBA

Walgreens Boots Alliance

$79.82

-2.11 (-2.58%)

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

CVS

CVS Health

$75.52

-3.02 (-3.85%)

AET

Aetna

$204.15

-3.535 (-1.70%)

UNH

UnitedHealth

$261.52

-4.52 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 02

    Dec

  • 04

    Dec

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
11/21/18
11/21
08:21
11/21/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$65.06

-7.9 (-10.83%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Recommendations
Jacobs Engineering analyst commentary  »

Jacobs Engineering shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Feb

IYT

iShares Transportation Average

$184.16

-5.75 (-3.03%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
11/21/18
11/21
08:20
11/21/18
08:20
General news
U.S. Durable Goods Preview »

U.S. Durable Goods…

08:20
11/21/18
11/21
08:20
11/21/18
08:20
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

XLK

Technology Select Sector SPDR

$64.22

-1.42 (-2.16%)

08:19
11/21/18
11/21
08:19
11/21/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$64.98

-2.17 (-3.23%)

08:19
11/21/18
11/21
08:19
11/21/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$101.42

-2.35 (-2.26%)

08:19
11/21/18
11/21
08:19
11/21/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$53.45

-1 (-1.84%)

08:19
11/21/18
11/21
08:19
11/21/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.85

-0.28 (-0.51%)

08:18
11/21/18
11/21
08:18
11/21/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.02

-0.93 (-1.66%)

08:18
11/21/18
11/21
08:18
11/21/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$89.97

-0.9 (-0.99%)

08:18
11/21/18
11/21
08:18
11/21/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$4.85

-1.04 (-17.66%)

08:18
11/21/18
11/21
08:18
11/21/18
08:18
Downgrade
Limbach Holding rating change  »

Limbach Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.